bibliographic entry 12414287 [be/12414287]
https://w3id.org/oc/corpus/be/12414287

is a
content
  • Cohen, RB, Jones, SF, Aggarwal, C, von Mehren, M, Cheng, J, Spigel, DR, Burris, HA. A phase I dose-escalation study of danusertib (PHA-739358) administered as a 24-hour infusion with and without granulocyte colony-stimulating factor in a 14-day cycle in patients with advanced solid tumors, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 2009, 15, 21, 6694, 6701, DOI: 10.1158/1078-0432.CCR-09-1445, PMID: 19825950
references